NM - Net merit Gene

Species: Bos taurus

Gene Type: unknown
Gene ID: 103753135

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (1)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-B0024 Prulifloxacin Inhibitor 98.05% Unkown

Clinical Phase

Bioactive Molecules (4)
Cat. No. Product Name Effect
Purity Phase
HY-111219 Parogrelil hydrochloride Inhibitor / Phase 3
HY-108060 Valopicitabine Inhibitor / Phase 2
HY-178820 NM-002 / Phase 2
HY-13705 NM-3 / Phase 1
Inhibitory Antibodies (1)
Cat. No. Product Name Effect
Purity Phase
HY-P991022 Ruxoprubart Inhibitor 95.541% Phase 2

Pre-clinical Phase

Bioactive Molecules (48)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-F0004 Fosribnicotinamide 99.94% Unkown
HY-13942 1-NM-PP1 Inhibitor 98.93% Unkown
HY-116022A 4-Nitrophenyl phosphate disodium hexahydrate 99.80% Unkown
HY-W021358 N,N,N′,N′-Tetramethyl-p-phenylenediamine 99.98% Unkown
HY-D0835A Hydroxylapatite (<50 nm) 99.05% Unkown
HY-F0004S Fosribnicotinamide-d4 99.55% Unkown
HY-10468 NM107 Inhibitor 99.90% Unkown
HY-F0004R Fosribnicotinamide (Standard) 99.76% Unkown
HY-116022 4-Nitrophenyl phosphate 99.48% Unkown
HY-D1691 BODIPY-581/591 NHS ester 98.67% Unkown
HY-W110929 Acid blue 1 91.07% Unkown
HY-W116336D Zinc oxide, <100 nm particle size Inhibitor 99.28% Unkown
HY-108060A Valopicitabine dihydrochloride Inhibitor 99.04% Unkown
HY-172174 Red Fluorescent PLGA nanoparticles, 100nm / Unkown
HY-179565 NM102 Inhibitor 99.77% Unkown
HY-D2422C Cy5-Paclitaxel bromide 92.94% Unkown
HY-D2422B Cy5-Paclitaxel 95.60% Unkown
HY-D2192 Ag2S-PEG-NH2 (1200 nm) / Unkown
HY-D2195 AgAuSe-PEG-NH2 (1000 nm) / Unkown
HY-RS05551 GNE Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-D2401F Cy5-Polystyrene microsphere (100nm) / Unkown
HY-108127 NAA-004 Inhibitor / Unkown
HY-120944 BAY-7598 Inhibitor / Unkown
HY-161650 PROTAC BRD4 Degrader-26 Degrader / Unkown
HY-168943 PLGA nanoparticles, 100nm / Unkown
HY-168943A PLGA nanoparticles, 200nm / Unkown
HY-168943B PLGA nanoparticles, 500nm / Unkown
HY-168947 Green Fluorescent PLGA nanoparticles, 100nm / Unkown
HY-168947A Green Fluorescent PLGA nanoparticles, 200nm / Unkown
HY-168947B Green Fluorescent PLGA nanoparticles, 500nm / Unkown
HY-174418 NM600 / Unkown
HY-178819 NM-001 / Unkown
HY-182387 NM404 / Unkown
HY-D2190 Ag2S Oil phase (1200 nm) / Unkown
HY-D2191 Ag2S-COOH (1200 nm) / Unkown
HY-D2193 AgAuSe Oil phase (1000 nm) / Unkown
HY-D2194 AgAuSe-COOH (1000 nm) / Unkown
HY-D2196 AgAuSe Oil phase (1120 nm) / Unkown
HY-D2197 AgAuSe-COOH (1120 nm) / Unkown
HY-D2198 AgAuSe-PEG-NH2 (1120 nm) / Unkown
HY-D3557 ICG PS (300nm) / Unkown
HY-172168 Orange Fluorescent PLGA nanoparticles, 100nm / Unkown
HY-172168A Orange Fluorescent PLGA nanoparticles, 200nm / Unkown
HY-172168B Orange Fluorescent PLGA nanoparticles, 500nm / Unkown
HY-172174A Red Fluorescent PLGA nanoparticles, 200nm / Unkown
HY-172174B Red Fluorescent PLGA nanoparticles, 500nm / Unkown
HY-185273 3'-O-(2-Nitrobenzyl)-dGTP / Unkown
HY-RS16774 Gne Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
Inhibitory Antibodies (2)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P99792 Ormutivimab 95% Unkown
HY-P991239 NM-02 Inhibitor / Unkown